Log on / register
BioMed Central home | Journals A-Z | Feedback | Support
 

This article is part of the supplement: Symposium Mammographicum 2006

Oral Presentation

Experience of quality assurance across BUPA screening centres

P Hollaway

Radiation Protection Service, Royal Surrey County Hospital, Guildford, Surrey, UK

corresponding author email

from Symposium Mammographicum 2006
Bournemouth, UK. 9–11 July 2006

Breast Cancer Research 2006, 8(Suppl 1):P17doi:10.1186/bcr1432

Published: 10 July 2006

Oral Presentation

BUPA's mammography quality assurance programme comprises an annual audit visit to 31 hospital-based screening centres by one of a team of three quality assurance mammographers. Clinical competence and mammographic film quality are assessed and technical quality control data are also collected. Monitoring of overall image quality is also addressed by a 'quarterly' test object film. A patient dose survey has been undertaken with exposure and breast thickness data collected from all sites.

The standard of mammography across screening centres is good and well within NHSBSP standards. Reject rates are less than 3% and are personalised to each radiographer, enabling feedback and learning. Continuing professional development is in place and sites have evidence of a system of peer review. Quality control checks are undertaken according to recommended standards and records are kept. The mean glandular dose for a lateral oblique film across all centres was 1.7 mGy, well below the recommended national reference dose level. Mean doses at individual hospitals ranged from approximately 1.1 mGy to 2.3 mGy. Image quality scores using the Leeds TORMAM are generally satisfactory and typical of elsewhere, with only a few films having scores less than optimum and driving a move to higher contrast film/screens at these sites.

Have something to say? Post a comment on this article!


© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions